Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Tina Vilsbøll

1-50 of 164 results

View this query on the Wikidata Query Service
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

scientific article
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

scientific article
Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

scientific article
The incretin system and its role in type 2 diabetes mellitus

scientific article published on 20 August 2008
Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

scientific article published in July 2003
Reduced Incretin Effect in Type 2 Diabetes

article by Filip K. Knop et al published 18 May 2007 in Diabetes
Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).

scientific article published on 11 August 2014
Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes

scientific article published on May 2011
The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action

scientific article
Role of gastrointestinal hormones in postprandial reduction of bone resorption

scientific article published in December 2003
Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans

scientific article
Impaired regulation of the incretin effect in patients with type 2 diabetes

scientific article published on 20 January 2011
Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake

scientific article published in September 2006
The effect of glucagon-like peptide 1 on cardiovascular risk

scientific article published on 31 January 2012
Glucagon-like peptide-1, glucose homeostasis and diabetes

scientific article published on 18 March 2008
Incretin-based therapies: viewpoints on the way to consensus

scientific article
The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty

scientific article published on 18 April 2013
Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

scientific article published on 03 June 2014
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes

scientific article published on 8 March 2011
Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

scientific article published on 8 March 2014
Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies

scientific article
Glucagon-like peptide 1 in health and disease

scientific article published on 01 July 2018
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism

scientific article published on 12 November 2015
Evidence of Extrapancreatic Glucagon Secretion in Man

article
Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution

article
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

scientific article
Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus

scientific article published on 16 October 2009
Patient preferences for diabetes management among people with type 2 diabetes in Denmark - a discrete choice experiment

scientific article published on 10 October 2011
Lixisenatide for type 2 diabetes mellitus

scientific article published on 11 March 2011
Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus

scientific article published on February 2007
Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes

scientific article published on 7 June 2016
Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes

scientific article
Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes

scientific article published on 11 December 2013
Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes

scientific article published on 26 January 2010
Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans

scientific article
Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes

scientific article published on 20 January 2017
The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects

scientific article published on 28 August 2006
Incretin-based therapy of type 2 diabetes mellitus

scientific article published on February 2009
Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma

scientific article published on 31 March 2016
Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial

scientific article published in July 2014
The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance

scientific article published on 13 July 2007
Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure

scientific article published on 7 October 2015
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy

scientific article published on 27 November 2017
Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty

scientific article published on 6 July 2013
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients

scientific article published on 28 December 2012
Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.

scientific article published on July 2014
Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects

scientific article published on 8 February 2012
Emerging GLP-1 receptor agonists

scientific article published on 09 September 2011
Patients with psoriasis are insulin resistant

scientific article published in February 2015
No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis

scientific article published in September 2003

Paulina is supported by:

About Paulina

Help